Cause-specific risks of childhood death in inherited epidermolysis bullosa

The Journal of Pediatrics
Jo-David FineC Suchindran

Abstract

To determine the cause-specific risks of death in children with epidermolysis bullosa (EB). Data were collected throughout the continental United States between 1986 and 2002 by the National EB Registry. The study design is cross-sectional (n = 3280), containing within it a nested randomly sampled longitudinal subcohort (n = 450). The risk of death during infancy and childhood was greatest in junctional EB (JEB), with cumulative and conditional risks of 40% to 44.7% by age 1 in both JEB subtypes, rising to 61.8% in children with JEB, Herlitz subtype and 48.2% in those with JEB, non-Herlitz subtype (JEB-nH) by age 15. In decreasing order, sepsis, failure to thrive, and respiratory failure were the major causes of death in children with JEB, plateauing by age 2 to 6. A small minority of children with epidermolysis bullosa simplex, Dowling-Meara subtype was at risk for death by age 1 (cumulative risk, 2.8%), with sepsis and respiratory failure accounting for cumulative risks of 1.9% and 0.9%. Only a minority of children with recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens subtype was at risk of death (cumulative risk = 8% by age 15). Renal failure also rarely accounted for death in children with JEB-nH. Infants and c...Continue Reading

References

Feb 1, 1986·Archives of Dermatology·L H BuchbinderA S Paller
Jul 1, 1994·The Annals of Otology, Rhinology, and Laryngology·A T LyosM Sulek
Sep 24, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jo-David FineUNKNOWN National Epidermolysis Bullosa Registry

❮ Previous
Next ❯

Citations

Mar 5, 2010·Pediatric Dermatology·Heather A Brandling-Bennett, Kimberly D Morel
Jun 29, 2011·Pediatric Rheumatology Online Journal·Despoina MaritsiClarissa A Pilkington
May 29, 2010·Orphanet Journal of Rare Diseases·Jo-David Fine
Jan 22, 2014·International Journal of Medical Microbiology : IJMM·Magdalena M van der Kooi-PolJan Maarten van Dijl
Aug 15, 2014·American Journal of Clinical Dermatology·Catherine S YangBrian M Cummings
Jan 22, 2015·BMC Medicine·Kenneth R GoldschneiderDanette Stanko-Lopp
Jan 9, 2016·The Journal of Investigative Dermatology·Dharshini SathishkumarCelia Moss
Feb 20, 2013·Seminars in Perinatology·Mercedes E Gonzalez
Nov 24, 2012·Seminars in Cutaneous Medicine and Surgery·Vasiliki NikolaouHensin Tsao
Apr 18, 2012·Journal of the American Academy of Dermatology·Jo-David Fine
Mar 6, 2012·Journal of the American Academy of Dermatology·Elena PopeGary Sibbald
Dec 1, 2009·Dermatologic Clinics·Eli Sprecher
Dec 1, 2009·Dermatologic Clinics·Kim B Yancey, Helmut Hintner
Aug 25, 2009·Journal of the American Academy of Dermatology·Jo-David Fine, Jemima E Mellerio
Aug 25, 2009·Journal of the American Academy of Dermatology·Jo-David Fine, Jemima E Mellerio
Mar 26, 2010·The Journal of Investigative Dermatology·Jason A BubierJohn P Sundberg
Nov 26, 2008·Journal of the American Academy of Dermatology·Jo-David FineChirayath Suchindran
Apr 20, 2012·The British Journal of Dermatology·W Y YuenM F Jonkman
Aug 23, 2012·International Journal of Dermatology·Carol Lattouf, Lawrence Schachner
May 18, 2013·Pediatrics International : Official Journal of the Japan Pediatric Society·Shigeki KoshidaHiroshi Shimizu
Jun 12, 2010·Annals of the New York Academy of Sciences·Jo-David Fine
Jul 31, 2013·Matrix Biology : Journal of the International Society for Matrix Biology·Amr SalamJohn A McGrath
Apr 15, 2014·The Journal of Dermatological Treatment·Kam Lun Ellis HonAlexander K C Leung
Nov 28, 2014·Science Translational Medicine·Noriko Umegaki-AraoAngela M Christiano
Jan 9, 2015·Indian Journal of Dermatology, Venereology and Leprology·Deepika Pandhi
Apr 16, 2010·The Journal of Investigative Dermatology·Noriyasu SakaiM Peter Marinkovich
Oct 13, 2016·The Journal of Investigative Dermatology·Monika PeschMonique Aumailley
Nov 17, 2017·Nature·Tobias HirschMichele De Luca
Jul 10, 2010·Current Opinion in Pediatrics·Jo-David Fine
Oct 20, 2017·Journal of Perinatology : Official Journal of the California Perinatal Association·S R HumphreyB Drolet
Jun 16, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Calogero Pagliarello, Stefano Tabolli
May 25, 2012·Experimental Dermatology·Magdalena M van der Kooi-PolJan Maarten van Dijl
May 14, 2010·Anais Brasileiros De Dermatologia·Nadia Aparecida Pereira de AlmeidaJulie Gomes Del Moro
Feb 11, 2011·Anais Brasileiros De Dermatologia·Zilda Najjar Prado de OliveiraValéria Aoki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.